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Summary
Components of osteoarthritis include increases in pericellular fibronectin and in chondrocyte â1 integrin expression. Events which follow
ligation of fibronectin to its chondrocyte-receptor, the integrin Æ5â1 include an assembly of a subplasmalemmal actin/rho A/focal adhesion
kinase signaling complex. In addition, nitric oxide (NO), a potential mediator of cartilage pathophysiology disrupts the cytoskeletal signaling
complex associated with integrin signaling. In these studies, we examined the relationship among integrin signaling, biosynthesis of S-35
sulfate containing proteoglycans and release of YKL-40 (a secretory glycoprotein) by comparing cell responses using cells plated on a
fibronectin-coated or polyHEME coated surfaces. We report that the release of proteoglycan and glycoprotein require anchorage dependent
signals by integrin costimulation. NO which disrupts the integrin signaling complex attenuates both cell responses. Taken together NO may
serve as a nonspecific ‘brake’ to prevent anabolic and catabolic injury responses.
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Recent studies have implicated nitric oxide (NO) as a
potential mediator of cartilage pathophysiology in arthritis.1
For example, excessive nitric oxide production is associ-
ated with autoimmune arthritis in MRL-lpr mice, collagen-
induced arthritis, adjuvant arthritis, zymosan induced
arthritis (ZIA).2–5 Regarding the later model, Van de Loo
and Coworkers investigated the role of NO in joint inflam-
mation and cartilage destruction during ZIA in wild type and
NOS2 deficient mice.6 NO exerts a major role in cartilage
destruction and caused a pronounced suppression of pro-
teoglycan synthesis and IGF-1 unresponsiveness of the
chondrocytes.
We recently reported that intracellular events which
follow ligation of fibronectin to its chondrocyte-receptor, the
integrin a 5b 1 include an ‘outside-in’ signal involving an
assembly of a subplasmalemmal actin/rho A/focal adhesion
kinase signaling complex which is associated with an
enhancement of proteoglycan synthesis. These findings
suggest that integrins are co-stimulatory to growth factor
responses. In these studies, we sought to examine the
selectiveness of the NO action by comparing the actions of
NO on proteoglycan biosynthesis and release of the glyco-
protein YKL-40, a catabolic mediator involved in tissue
remodeling.7 We demonstrate that NO attenuates both
proteoglycan biosynthesis and glycoprotein secretion.
These observations provide a basis by which NO
can interfere with cartilage homeostasis by affecting
chondrocyte extracellular matrix-dependent processes.Materials and Methods
CELLS AND REAGENTS
Bovine articular chondrocytes were obtained from the
bovine fetlock joint as described.8 Cells were cultured in
monolayer in DME plus 10% FBS. Monolayer cultures of399passage one bovine articular chondrocytes were plated
onto coverslips and cultured in 24 well plates. The NO
surrogate SNO-GSH was prepared from red agarose as
described.9 Fibronectin or albumin was applied to latex
beads and fibronectin or polyHEME plates were prepared
10MEASUREMENTS INVOLVING ANALYSIS OF PROTEOGLYCAN AND
GLYCOPROTEIN
Proteoglycan synthesis was determined by measuring
S-35 Na2SO4 incorporation into protein as described by
Clancy and coworkers.10 The secretion of gpYKL40 was
measured by analyzing cell fluids using an ELISA assay
and following exactly the instructions provided by the
manufacturer (Condrex).BEAD ASSAY
Chondrocytes were incubated with beads (20 min). Cells
were then washed, were fixed in paraformaldehyde. Cells
were stained with rhodamine phalloidin and analyzed by
immunofluorescence microscopy. The procedure allows
quantitation of the percentage of beads with circumferential
localization relative to the total number of beads (% positive
beads).Results and Discussion
We examined the ability of bovine chondrocytes to signal
following interaction of fibronectin coated latex beads to the
surface â1 integrin Æ5â1, in the presence or absence of the
nitric oxide surrogate, S-nitrosoglutathione (SNO-GSH).
Exposure of chondrocytes to SNO-GSH (concentration
varied) did not affect the total number of beads bound per
400 R. Clancy: Nitric oxide alters chondrocyte functioncell nor the clustering of Æ5â1 integrin (not shown). How-
ever, the intracellular assembly of F-actin was blocked by
SNO-GSH (Table I). These data are similar to responses
elicited by authentic NO and ‘NO inducing’ cytokine treat-
ments.10 Thus, SNO-GSH inhibits the assembly of the
intracellular activation complex, but not affecting the extra-
cellular aggregation of Æ5â1 integrin.
We next examined the consequences of fibronectin
ligation on basal cell function involving the proteoglycan
and glycoprotein (Table I) by comparing cell responses
using cells plated on a fibronectin-coated or poIyHEME
coated surfaces. S-35 sulfate incorporation into proteo-
glycan was selected to measure the capacity of serum to
support chondrocyte proteoglycan biosynthesis. Matrix was
required to support constitutive synthesis as the capacity of
cells on a fibronectin coated surface was markedly reduced
on a polyHEME coated surface (1008 vs 57). Exposure of
cells to SNO-GSH (0.1 mM) reduced the constitutive cell
response from 1008±83 to 221±20 (P<0.02). Surprisingly,
we found that the capacity of NO to turn off constitutive
biosynthesis was not restricted to S-35 sulfate containing
proteoglycans. We found in experiments which utilized a
highly specific ELISA assay to measure YKL-40 (secretory
glycoprotein,7 that exposure of cells to SNO-GSH reduced
the constitutive cell response from 79±1 to 46±1 ng/mg
(P<0.05). These data indicate that anchorage signals pro-
mote constitutive proteoglycan release and glycoprotein
synthesis. SNO-GSH, possibly by preventing the assembly
of a complete focal activation complex which colocalizes
with the cytoplasmic tail of Æ5â1, blocks that signal.
Thus, in chondrocytes, (1) constitutive and elicited cell
responses require anchorage dependent signals which areprovided by integrin costimulation and (2) NO disrupts the
integrin signaling complex and makes cells anergic pre-
venting participation in anabolic and catabolic injury
responses.Table I





(% positive beads, actin) 73±11 14± 9
Proteoglycan biosynthesis 35-S04
(uptake, cpm/20 h) 1008±83 221±20
Glycoprotein secretion gpYKL40 (ng/mg) 79± 1 46± 1
*Chondrocyte were cultured in RPMI plus 0.5% serum. Cells on
coverslips were exposed to fibronectin coated beads with or
without SNO-GSH (0.1 mM) and the clustering of actin was
measured as described in bead assay (Methods). In separate
experiments, chondrocytes were plated on a fibronectin coated
surface with or without SNO-GSH (0.1 mM, added 3× daily; 18 h);
then cells were given 35-S04 (20 h). Glycoprotein (cell fluid, ELISA
assay) and proteoglycan (total cell lysate; isotope incorporation
into protein) were determined.References
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